Dyslipidemia: Clinical Trials

470 trials for Dyslipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

326 completed, 39 unknown, 31 recruiting, 26 not yet recruiting. 145 Not applicable, 83 Phase 3, 59 Phase 1, 55 Phase 2, 51 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable145Completed 88, Recruiting 17, Not yet recruiting 15, Unknown 14, Active not recruiting 4, Terminated 3, Enrolling by invitation 2, Suspended 1, Withdrawn 1
Phase 383Completed 61, Terminated 11, Unknown 5, Withdrawn 4, Recruiting 2
Phase 159Completed 48, Recruiting 4, Not yet recruiting 3, Active not recruiting 1, Enrolling by invitation 1, Terminated 1, Withdrawn 1
Phase 255Completed 43, Terminated 6, Not yet recruiting 2, Unknown 2, Enrolling by invitation 1, Withdrawn 1
Phase 451Completed 39, Unknown 6, Recruiting 2, Terminated 2, Not yet recruiting 1, Withdrawn 1
Early Phase 11Terminated 1

Follow Dyslipidemia: new trials by email Literature Review of Dyslipidemia trials Research Report on Dyslipidemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient-engaged Development and Testing of Educational Content on Side Effects of Statins
Educational content on statin side effects - Dyslipidemia
Not applicableSuspendedWeill Medical College of Cornell University302028-09-012026-09-23
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
Pecan, Control - Nutrition, Healthy, Dyslipidemia
Not applicableNot yet recruitingUniversity of Georgia902027-03-012026-08-11
Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health
Synbiotic (LAB12 and SWEOAT® Bran), Oat-based Placebo - Dyslipidemia
Phase 2Not yet recruitingUniversiti Teknologi Mara1902026-12-022026-11-05
Multimodal AI-Driven Out-of-Hospital Management for Hypertension and Cardiometabolic Risk
Hybrid AI-Enabled Out-of-Hospital Health Management, Standard Out-of-Hospital Guidance - Hypertension, Hyperglycemia
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases1502026-11-032026-11-04
Study of the Safety and Efficacy of Prenofitol Tablets
1 tablet of Prenofitol, 2 tablets of Prenofitol, 1 tablet of placebo - Dyslipidemia
Phase 2Not yet recruitingGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation1602026-11-022026-11-02
The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus
Diabetic Nephropathy, Dyslipidemia
Not yet recruitingAssiut University842026-10-012026-03-17
Community Physical Exercise Program in Chronic Disease
Physical Exercise - Osteoarthritis Pain, Myocardial Infarction (MI)
Not applicableNot yet recruitingAssociação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv1502026-10-012026-09-10
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C Levels
HS-10582, Placebo - Dyslipidemia
Phase 1Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.762026-09-302026-08-20
Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome
bempedoic acid, Ezetimibe, High-Intensity Statin Therapy - Acute Coronary Syndromes, Dyslipidemia
Phase 4RecruitingTaipei Medical University Hospital4002026-08-262026-09-17
A Retrospective Real-World Cohort Study
No treatment given - Obesity, Type 2 Diabetes (T2D)
Active not recruitingNovo Nordisk A/S1000002026-08-202026-09-30
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
Pharmacist-led lipid optimization pathway - ACS (Acute Coronary Syndrome), Hyperlipidemia
Not applicableRecruitingUniversity of Alberta20002026-08-102026-09-09
Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers
Test Drug, Reference Drug - Hypercholerolemia, Dyslipidemia
Phase 1CompletedAJU Pharm Co., Ltd.612026-08-062026-09-09
Effect of macaúba Oil Combined With Green Exercises
Macauba oil, Placebo, Daytime Green Exercise - Stress Mental, Dyslipidemia
Not applicableNot yet recruitingFederal University of Minas Gerais602026-08-012026-07-20
Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes
Type 2 Diabetes Mellitus, Obesity
Not yet recruitingSinai University1502026-07-252026-07-27
Polypills Approach for Multiple Cardiovascular Risk Factors
Fixed-Dose Combination Strategy - Hypertension, Dyslipidemia
Not applicableRecruitingChina Medical University, China82522026-07-112026-09-16
A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers
Investigational Product 1, Investigational Product 2, Investigational Product 1 + Investigational Product 2 - Hypertension, Dyslipidemia
Phase 1RecruitingKorea United Pharm. Inc.362026-07-012026-07-06
Effects of Policosanol and Exercise on Fitness and Lipids in People With Elevated Blood Lipids
Policosanol, Placebo, Concurrent Exercise Training - Dyslipidemia, Elevated Blood Lipids
Not applicableNot yet recruitingMahidol University1202026-06-222026-07-17
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
Test Drug, Reference Drug - Hypercholesterolemia, Dyslipidemia
Phase 1CompletedAJU Pharm Co., Ltd.412026-06-112026-07-10
Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome
Kodo Millet Porridge Beverage - Obesity & Overweight, Metabolic Syndrome
Not applicableRecruitingJSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH502026-06-012026-07-14
Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth
Nutrition education and produce prescription card - Dyslipidemia, Hypertension
Not applicableNot yet recruitingBoston Children's Hospital1502026-06-012026-04-22

Showing 20 of 470. Sign in to see all of them.

Narrower conditions

Dyslipidemias (470)  ·  Hypertension (101)  ·  Obesity (80)  ·  Diabetes Mellitus (64)  ·  Hypercholesterolemia (50)  ·  Diabetes Mellitus, Type 2 (49)  ·  Cardiovascular Diseases (46)  ·  Metabolic Syndrome (39)  ·  Overweight (32)  ·  Insulin Resistance (27)  ·  Hyperlipidemias (23)  ·  Atherosclerosis (21)  ·  Inflammation (17)  ·  Coronary Artery Disease (15)  ·  Coronary Disease (12)

Broader conditions

Nutritional and Metabolic Diseases (470)  ·  Lipid Metabolism Disorders (468)  ·  Metabolic Diseases (466)  ·  Glucose Metabolism Disorders (147)  ·  Vascular Diseases (138)  ·  Pathological Conditions, Signs and Symptoms (121)  ·  Cardiovascular Diseases (115)  ·  Endocrine System Diseases (115)  ·  Signs and Symptoms (101)  ·  Nutrition Disorders (90)  ·  Overnutrition (90)  ·  Body Weight (87)  ·  Overweight (58)  ·  Hyperinsulinism (52)  ·  Diabetes Mellitus (50)

Interventions

Atorvastatin (35)  ·  Rosuvastatin Calcium (30)  ·  Fenofibrate (20)  ·  Simvastatin (20)  ·  Niacin (17)  ·  pitavastatin (13)  ·  Ezetimibe (12)  ·  Exercise (10)  ·  2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid (9)  ·  Diet (9)  ·  Metformin (9)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (8)  ·  MK-0524 (8)  ·  CKD-519 (5)  ·  Ezetimibe, Simvastatin Drug Combination (5)

Sponsors

AstraZeneca (25)  ·  Merck Sharp & Dohme LLC (19)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (10)  ·  Pfizer (9)  ·  Abbott (8)  ·  Chong Kun Dang Pharmaceutical (8)  ·  UCSF Benioff Children's Hospital Oakland (8)  ·  Kowa Research Europe (7)  ·  Kowa Research Institute, Inc. (7)  ·  John Sievenpiper (6)  ·  Novartis (6)  ·  Sanofi (6)  ·  Amgen (5)  ·  Daewoong Pharmaceutical Co. LTD. (5)  ·  Organon and Co (5)

Countries

United States (152)  ·  South Korea (48)  ·  Canada (40)  ·  Netherlands (24)  ·  Italy (23)  ·  Denmark (21)  ·  United Kingdom (21)  ·  Germany (19)  ·  Spain (19)  ·  China (17)  ·  Poland (16)  ·  Russia (16)  ·  Sweden (16)  ·  Australia (13)  ·  Brazil (13)

Top investigators

David JA Jenkins, MD, PhD, DSc (6)  ·  Ronald M Krauss, MD (6)  ·  Dragos Budinski, Med Dr. (5)  ·  John L Sievenpiper, MD, PhD (5)  ·  Russell J de Souza, ScD, RD (5)  ·  Cyril WC Kendall, PhD (4)  ·  Ronald P Mensink, PhD (3)  ·  Wen-Chih Wu, MD (3)

Results publications

PMID 18783301, PMID 28181260, PMID 37994400, PMID 20136164, PMID 20573750, PMID 29037448, PMID 33078867, PMID 21174145, PMID 21518985, PMID 22263674, PMID 24782116, PMID 38504437, PMID 16291982, PMID 16779380, PMID 16990155, PMID 17090635, PMID 17238648, PMID 17238690, PMID 17384435, PMID 17416370, PMID 17533211, PMID 17626713, PMID 17644623, PMID 18312764, PMID 18375417, PMID 18509206, PMID 18567058, PMID 18606913, PMID 18653575, PMID 18687759, PMID 18996523, PMID 18999065, PMID 19047532, PMID 19116237, PMID 19171813, PMID 19217176, PMID 19254366, PMID 19267708, PMID 19301936, PMID 19331435, PMID 19365563, PMID 19407658, PMID 19614793, PMID 19785568, PMID 19828712, PMID 19841042, PMID 19966072, PMID 20080236, PMID 20110022, PMID 20168204

NIH funding

2005 (4), 2015 (2), K23GM100372 (2), OT2HL158287 (2), 2004 (1), 2009 (1), 2014 (1), 2016 (1), 2023 (1), 2025 (1), K23AT002862 (1), K23DK075360 (1), K23HL085308 (1), K23HL091130 (1), P20RR016464 (1)